NDC 50268-554-11 - Methotrexate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50268-554
- Requested NDC
- 50268-554-11
- Package NDCs from labels
- 50268-554-11, 50268-554-15
- Manufacturer
- AvPAK
- Effective date
- 2026-01-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Methotrexate - AvPAK | AvPAK | 2026-01-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50268-554-11 | Methotrexate | 1 in 1 BLISTER PACK | TABLET | 1 | 1 | |
| 50268-554-15 | Methotrexate | 50 in 1 BOX | TABLET | 50 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50268-554-11 | EA - Each | 50268-554 | 0668ad87-9e70-4d65-99f0-c1b350413a60 | 1 | 2026-03-17 |
| 50268-554-15 | EA - Each | 50268-554 | 4e603a55-a2d1-40a9-9ae9-9b8e47088888 | 1 | 2026-03-17 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Methotrexate | METHOTREXATE | Accord Healthcare, Inc. | dd035a9f-cd40-4314-b9d8-2294b8a924e2 | 2026-09-04 | Boxed warning, Warnings, Adverse reactions | YL5FZ2Y5U1 |
| Methotrexate | METHOTREXATE | A-S Medication Solutions | 22e10810-16fb-4c84-bccf-972405b77ef8 | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | 105585 |
| Methotrexate | METHOTREXATE | AvKARE | 757d6cef-6696-7a1c-8074-01258aaa8bdd | 2026-07-23 | Boxed warning, Adverse reactions | 105585 |
| Methotrexate | METHOTREXATE | Bryant Ranch Prepack | b6e61c50-024a-494f-b04c-100fb371a837 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | 105585 |
| JYLAMVO | METHOTREXATE | SHORLA ONCOLOGY INC. | 96e931f5-51ae-4bdf-a441-bb0dd26d4c0e | 2026-06-08 | Boxed warning, Warnings, Adverse reactions | YL5FZ2Y5U1 |
| Methotrexate | METHOTREXATE | Bryant Ranch Prepack | 0b54b5c4-2466-4f85-b9a0-ad93ec4a06a1 | 2026-06-05 | Boxed warning, Warnings, Adverse reactions | 105585 |
| Methotrexate | METHOTREXATE | Teva Pharmaceuticals USA, Inc. | 9b34b1d8-d125-41a2-9f6f-3fab67b573bd | 2026-06-04 | Boxed warning, Warnings, Adverse reactions | 105585 |
| Methotrexate | METHOTREXATE | Major Pharmaceuticals | 2a6afc4c-819d-4ba9-8040-4504519c116a | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | ANDA207812 105585 YL5FZ2Y5U1 |
| Xatmep | METHOTREXATE | Azurity Pharmaceuticals, Inc. | aec9984e-34c5-481b-b6bf-9bb5caf1daf8 | 2026-05-28 | Boxed warning, Warnings, Adverse reactions | YL5FZ2Y5U1 |
| Methotrexate | METHOTREXATE | Accord Healthcare Inc. | 874c7f43-a3be-4236-89cc-24c44e3c5813 | 2026-05-27 | Boxed warning, Warnings, Adverse reactions | 105585 |
| METHOTREXATE | METHOTREXATE | Bryant Ranch Prepack | 4a04756f-e1c9-4d1e-b309-7be31c9176d6 | 2026-05-26 | Boxed warning, Warnings, Adverse reactions | 105585 |
| Methotrexate Sodium | METHOTREXATE SODIUM | Elite Laboratories, Inc. | 89c05ea3-3be1-46dd-b112-29c436fd7289 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | 105585 |
| Methotrexate | METHOTREXATE SODIUM | Sun Pharmaceutical Industries, Inc. | 8f1260de-b60c-4f0e-8af6-0e957b0a281b | 2026-05-21 | Boxed warning, Warnings, Adverse reactions | 105585 |
| Methotrexate Sodium | METHOTREXATE SODIUM | Hikma Pharmaceuticals USA Inc. | d71b1856-99d8-4a9e-9189-f87b6675f80a | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 105585 |
| Methotrexate | METHOTREXATE | Bryant Ranch Prepack | 4741a44f-0d0b-4380-84f6-231a8d1560fb | 2026-05-20 | Boxed warning, Warnings, Adverse reactions | 105585 |
| METHOTREXATE | METHOTREXATE | Alembic Pharmaceuticals Inc. | 04a95db9-a124-4b97-bd71-1c37a6b3b0c8 | 2026-05-18 | Boxed warning, Warnings, Adverse reactions | 105585 |
| Methotrexate | METHOTREXATE | Zydus Pharmaceuticals USA Inc. | 948e0bab-6524-4b87-9853-1799d4415558 | 2026-05-09 | Boxed warning, Warnings, Adverse reactions | ANDA207812 68382-775 105585 5d9b7269-19d4-4d2c-b252-f3ff759dffa5 948e0bab-6524-4b87-9853-1799d4415558 YL5FZ2Y5U1 |
| Methotrexate | METHOTREXATE | Mylan Pharmaceuticals Inc. | 70c09984-2b36-424f-8b27-3fd0cd4e833d | 2026-05-07 | Boxed warning, Warnings, Adverse reactions | 105585 |
| Methotrexate | METHOTREXATE | Aurobindo Pharma Limited | 09931d44-a3f8-49dc-a3f2-b527ee4214bf | 2026-05-07 | Boxed warning, Warnings, Adverse reactions | 105585 |
| Methotrexate | METHOTREXATE | NuCare Pharmaceuticals, Inc. | 50b2cfc7-dfe4-4406-e063-6294a90a2527 | 2026-04-30 | Boxed warning, Warnings, Adverse reactions | 105585 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.